Turner Christopher Durant
- SEC CIK
- 0001862146
In the past year, 1 open-market sale filing worth $721.3K and no purchases.
Current role at each company
- NUVL Nuvalent, Inc.Chief Medical Officeras of Jul 15, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $721.3K
- 1 filing
- Net
- −$721.3K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Turner Christopher Durant as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5-6 | 2 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −7.42K | $97.25 | −$721.3K | −11.9%55.1K after | 7 lots10b5-1 |
| Jan 8, 2025 (view filing) | Jan 6 | 2 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −4.02K | $79.68 | −$320.0K | −6.0%62.5K after | 3 lots10b5-1 |
| Oct 6, 2023 (view filing) | Oct 4 | 2 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −8.00K | $54.04 | −$432.0K | −35.5%14.5K after | 6 lots10b5-1 |
| Jul 28, 2023 (view filing) | Jul 26-28 | 2 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −5.03K | $47.95 | −$241.2K | −25.7%14.5K after | 2 lots10b5-1 |
| Jul 24, 2023 (view filing) | Jul 20-24 | 4 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −300 | $46.81 | −$14.0K | −2.0%14.5K after | 2 lots10b5-1 |
| Jun 7, 2023 (view filing) | Jun 5 | 2 days | Turner Christopher DurantChief Medical Officer | SSaleClass A Common Stock | −10.2K | $44.86 | −$459.1K | −41.4%14.5K after | 10b5-1 |